CEACAM5 and pachyonychia congenita: The positivity rate of tumor markers in patients with stage 0 PC has been reported to be 2.7% for carcinoembryonic antigen, 11% for CA19-9, 4.8% for Duke pancreatic monoclonal antigen type 2, and 10% for s-pancreas antigen-1 [8].